Approval · Notice of Compliance 7870 · 2006
M-ESLON: Notice of Compliance 7870
Issued April 7, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7870
- Date
- April 7, 2006
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Narcotic analgesic
Products in this notice
Medicinal ingredients
- MORPHINE SULFATE 10 MG per CAP
- MORPHINE SULFATE 15 MG per CAP
- MORPHINE SULFATE 30 MG per CAP
- MORPHINE SULFATE 60 MG per CAP
- MORPHINE SULFATE 100 MG per CAP
- MORPHINE SULFATE 200 MG per CAP